<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="174035">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00830271</url>
  </required_header>
  <id_info>
    <org_study_id>C624/07</org_study_id>
    <nct_id>NCT00830271</nct_id>
  </id_info>
  <brief_title>Vicryl Plus and Monocryl Plus in Breast Surgery</brief_title>
  <official_title>Pilot Study of Vicryl Plus and Monocryl Plus in Breast Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiff and Vale University Health Board</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiff and Vale University Health Board</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomised pilot study comparing conventional sutures (Vicryl and Monocryl) with
      antiseptic coated equivalents (Vicryl plus andf Monocryl plus) in elective breast surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of surgical site infection</measure>
    <time_frame>6-7 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>estimation time in hospital and return to work numbers of haematomas and seromas</measure>
    <time_frame>6-9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Breast Cancer Surgery</condition>
  <arm_group>
    <arm_group_label>Vicryl plus/Monocryl plus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vicryl plus and Monocryl plus is the active comparator arm. These are the &quot;active&quot; sutures, coated with triclosan antiseptic, being used in the closure of skin and subcutaneous tissues after breast cancer surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vicryl/monocryl</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>&quot;Plain&quot; Vicryl or Monocryl suture currently the standard which are not coated with triclosan, serve as the control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vicryl plus and Monocryl plus</intervention_name>
    <description>closure of skin and subcutaneous tissues</description>
    <arm_group_label>Vicryl plus/Monocryl plus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>wound closure with Vicryl and Monocryl</intervention_name>
    <description>wound closure skin and subcutaneous tissues</description>
    <arm_group_label>vicryl/monocryl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients over 18 years old who attend the Cardiff and Vale NHS Trust for elective
             breast cancer surgery

        Exclusion Criteria:

          -  patients unable to give consent or comply with follow up

          -  patients undergoing surgery for benign disease

          -  patients with inflammatory cancers or skin ulceration

          -  patients having neo-adjuvant chemotherapy or radiotherapy

          -  patients with known allergy to triclosan antiseptic

          -  patients with immune deficiency diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiff and Vale NHS Trust</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF14 4XN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <lastchanged_date>February 2, 2015</lastchanged_date>
  <firstreceived_date>January 21, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Professor David Leaper</name_title>
    <organization>Cardiff University/Cardiff and Vale NHS Trust</organization>
  </responsible_party>
  <keyword>surgical site infection</keyword>
  <keyword>wound complications</keyword>
  <keyword>suture</keyword>
  <keyword>antiseptic</keyword>
  <keyword>wound closure</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
